Moderate to high throughput in vitro binding kinetics for drug discovery
Frontiers in Bioscience · 2016 · 8 (2) · 278-297
DOI: 10.2741/s462 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience, 2016. Verfasst von Rumin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: In vitro Pharmacology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey, rumin.zhang@merck.com. Die Arbeit wurde bisher 20-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- In vitro Pharmacology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey, rumin.zhang@merck.com.
- In vitro Pharmacology, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey, USA.
Zitieren
APA
Zhang, R., Barbieri, C. M., Garcia-Calvo, M., Myers, R. W., McLaren, D., & Kavana, M. (2016). Moderate to high throughput in vitro binding kinetics for drug discovery. Frontiers in Bioscience, 8(2), 278-297. https://doi.org/10.2741/s462
Vancouver
Zhang R, Barbieri CM, Garcia-Calvo M, Myers RW, McLaren D, Kavana M. Moderate to high throughput in vitro binding kinetics for drug discovery. Frontiers in Bioscience. 2016;8(2):278-297. doi:10.2741/s462
BibTeX
@article{Zhang2016,
author = {Zhang, Rumin and Barbieri, Christopher M and Garcia-Calvo, Margarita and Myers, Robert W and McLaren, David and Kavana, Michael},
title = {Moderate to high throughput in vitro binding kinetics for drug discovery},
journal = {Frontiers in Bioscience},
year = {2016},
volume = {8},
number = {2},
pages = {278--297},
doi = {10.2741/s462}
}
EUVIMED